Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanism of Action of Crisaborole in Atopic Dermatitis
NCT03233529Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jul 2017
- Primary completion
- May 2018
- Countries
- 1
01
Overview
A Phase 2 trial of AN2728 ointment vehicle in atopic dermatitis (AD), sponsored by Pfizer. Started Jul 2017; status: completed.
02
Drugs
AN2728 ointment vehicle
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03233529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03233529.